Kwang Dong Pharmaceutical Co., Ltd. 009290.KS Stock
Kwang Dong Pharmaceutical Co., Ltd. Price Chart
Kwang Dong Pharmaceutical Co., Ltd. 009290.KS Financial and Trading Overview
Kwang Dong Pharmaceutical Co., Ltd. stock price | 6850 KRW |
Previous Close | 6470 KRW |
Open | 6450 KRW |
Bid | 6550 KRW x 0 |
Ask | 6570 KRW x 0 |
Day's Range | 6400 - 6720 KRW |
52 Week Range | 5370 - 7490 KRW |
Volume | 135.99K KRW |
Avg. Volume | 104.71K KRW |
Market Cap | 276.06B KRW |
Beta (5Y Monthly) | 0.74589 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 100 (1.50%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
009290.KS Valuation Measures
Enterprise Value | 226.54B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.18700224 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.153 |
Enterprise Value/EBITDA | 3.854 |
Trading Information
Kwang Dong Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.74589 |
52-Week Change | 4.18% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7490 KRW |
52 Week Low | 5370 KRW |
50-Day Moving Average | 6096.6 KRW |
200-Day Moving Average | 6016.35 KRW |
009290.KS Share Statistics
Avg. Volume (3 month) | 104.71K KRW |
Avg. Daily Volume (10-Days) | 134.83K KRW |
Shares Outstanding | 41.08M |
Float | 34.13M |
Short Ratio | N/A |
% Held by Insiders | 18.28% |
% Held by Institutions | 13.83% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 126.00% |
Payout Ratio | 0.1342 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.07% |
Operating Margin (ttm) | 3.05% |
Gross Margin | 19.72% |
EBITDA Margin | 3.98% |
Management Effectiveness
Return on Assets (ttm) | 3.11% |
Return on Equity (ttm) | 6.09% |
Income Statement
Revenue (ttm) | 1.48T KRW |
Revenue Per Share (ttm) | 35935.39 KRW |
Quarterly Revenue Growth (yoy) | 14.29% |
Gross Profit (ttm) | 280B KRW |
EBITDA | 58.78B KRW |
Net Income Avi to Common (ttm) | 30.63B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 85.09% |
Balance Sheet
Total Cash (mrq) | 242.26B KRW |
Total Cash Per Share (mrq) | 5897.15 KRW |
Total Debt (mrq) | 171.77B KRW |
Total Debt/Equity (mrq) | 30.72 KRW |
Current Ratio (mrq) | 1.726 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 63.06B KRW |
Levered Free Cash Flow (ttm) | 29.85B KRW |
Profile of Kwang Dong Pharmaceutical Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | Gasan Building |
ZIP | N/A |
Phone | 82 2 6006 7777 |
Website | https://www.ekdp.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
Q&A For Kwang Dong Pharmaceutical Co., Ltd. Stock
What is a current 009290.KS stock price?
Kwang Dong Pharmaceutical Co., Ltd. 009290.KS stock price today per share is 6850 KRW.
How to purchase Kwang Dong Pharmaceutical Co., Ltd. stock?
You can buy 009290.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kwang Dong Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Kwang Dong Pharmaceutical Co., Ltd. is 009290.KS.
Which industry does the Kwang Dong Pharmaceutical Co., Ltd. company belong to?
The Kwang Dong Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Kwang Dong Pharmaceutical Co., Ltd. have in circulation?
The max supply of Kwang Dong Pharmaceutical Co., Ltd. shares is 40.08M.
What is Kwang Dong Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Kwang Dong Pharmaceutical Co., Ltd. PE Ratio is now.
What was Kwang Dong Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Kwang Dong Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Kwang Dong Pharmaceutical Co., Ltd. company belong to?
The Kwang Dong Pharmaceutical Co., Ltd. sector is Healthcare.